Skip to main content
. 2020 Apr 2;24(10):5640–5651. doi: 10.1111/jcmm.15225

TABLE 1.

Baseline characteristics

  Acute kidney injury (n = 48) No acute kidney injury (n = 24) P
Male sex 29 (60.4) 17 (70.8) .386
Age (y) 61 (48, 74) 71 (57, 76) .203
Body mass index (kg/m2) 23.3 (20.8, 27.1) 24.1 (22.0, 27.0) .591
Baseline sCr (mg/dL) 0.98 (0.71, 1.50) 0.83 (0.73, 0.93) .057
Baseline MDRD‐GFR (mL/min/1.73 m2) 72.7 (43.0, 105.2) 85.5 (77.7, 91.2) .068
Chronic kidney disease     .030
Stage 1 12 (25.0) 8 (33.3)  
Stage 2 13 (27.1) 16 (66.7)  
Stage 3 12 (25.0) 0 (0.0)  
Stage 4 3 (6.2) 0 (0.0)  
Unknown 8 (16.7) 0 (0.0)  
Hypertension 25 (52.1) 15 (62.5) .402
Diabetes mellitus 21 (43.8) 7 (29.2) .231
Liver disease 10 (20.8) 1 (4.2) .064
Systolic BP (mm Hg) 107 (92, 125) 139 (117, 166) <.001
Serum creatinine (mg/dL) 2.65 (1.82, 3.83) 0.99 (0.84, 1.12) <.001
MDRD‐GFR (mL/min/1.73 m2) 21.5 (15.2, 36.0) 73.7 (56.9, 84.4) <.001
Plasma cMet (ng/mL) 475.0 (385.9, 616.7) 371.9 (302.3, 421.3) <.001
Plasma HGF (pg/mL) 5659.2 (3533.1, 10 757.7) 353.4 (32.8, 958.6) <.001

The data are presented as the median (25th and 75th percentiles) or as a number (percentage, %).

Abbreviations: BP, blood pressure; GFR, glomerular filtration rate; HGF, hepatocyte growth factor; sCr, serum creatinine.